Arrowhead Research | Lånekapital



Loan Capital Endring Dato
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Arrowhead Research USD 407.79M 14.61M 2024-12
Incyte USD 33.54M 5.32M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Ligand Pharmaceuticals USD 0 0 2024-12
Merck USD 34.46B 520M 2024-12
Moderna USD 39M 586M 2024-12
Novartis USD 22.93B 2.41B 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
TG Therapeutics USD 244.43M 271K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 115.16M 104.99M 2024-12



Arrowhead Research Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.